Zacks Company Profile for Moderna, Inc. (MRNA : NSDQ) |
|
|
|
Company Description |
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Number of Employees: 2,700 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $136.25 |
Daily Weekly Monthly
 |
20 Day Moving Average: 6,845,117 shares |
Shares Outstanding: 397.76 (millions) |
Market Capitalization: $54,194.73 (millions) |
Beta: 1.70 |
52 Week High: $497.49 |
52 Week Low: $119.01 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-2.91% |
6.30% |
12 Week |
-9.97% |
1.19% |
Year To Date |
-46.35% |
-34.46% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Stephane Bancel - Chief Executive Officer
Noubar B. Afeyan - Chairman
David Meline - Chief Financial Officer
Stephen Berenson - Director
Sandra Horning - Director
|
|
Peer Information
Moderna, Inc. (CORR.)
Moderna, Inc. (RSPI)
Moderna, Inc. (CGXP)
Moderna, Inc. (BGEN)
Moderna, Inc. (GTBP)
Moderna, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 60770K107
SIC: 2836
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 397.76
Most Recent Split Date: (:1)
Beta: 1.70
Market Capitalization: $54,194.73 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $4.72 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $27.22 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 10.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 6.51% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/04/22 |
|
|
|
|